Trial Profile
Phase 2 study of DLX 105 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2015
Price :
$35
*
At a glance
- Drugs DLX 105 (Primary)
- Indications Behcet's syndrome; Crohn's disease; Osteoarthritis; Plaque psoriasis
- Focus Pharmacokinetics
- 05 Oct 2015 New trial record